Literature DB >> 11487480

CFTR and pseudomonas infections in cystic fibrosis.

L E Tatterson1, J F Poschet, A Firoved, J Skidmore, V Deretic.   

Abstract

Pseudomonas aeruginosa is a significant threat to human health as it is frequently recalcitrant to conventional antibacterial therapy. This ubiquitous gram-negative bacterium is notorious for its nutritional and ecological flexibility and its resistance to both antibiotic treatments and sanitary measures. These properties contribute to its prominence as a leading source of opportunistic nosocomial (hospital acquired) and a less appreciated, but significant cause of community acquired infections. P. aeruginosa remains a considerable problem for patients with burns, neutropenic individuals, and cystic fibrosis patients (CF). In this review, we will address the current issues in P. aeruginosa infections in CF. A major emphasis will be placed on the factors predisposing CF patients to colonization with P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11487480     DOI: 10.2741/tatterso

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  11 in total

1.  Simple method for assaying colistin methanesulfonate in plasma and urine using high-performance liquid chromatography.

Authors:  Jian Li; Robert W Milne; Roger L Nation; John D Turnidge; Kingsley Coulthard; Jason Valentine
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

2.  Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa.

Authors:  Phillip J Bergen; Jian Li; Craig R Rayner; Roger L Nation
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

3.  Global genomic analysis of AlgU (sigma(E))-dependent promoters (sigmulon) in Pseudomonas aeruginosa and implications for inflammatory processes in cystic fibrosis.

Authors:  Aaron M Firoved; J Cliff Boucher; Vojo Deretic
Journal:  J Bacteriol       Date:  2002-02       Impact factor: 3.490

4.  Discovery of Two Bacterial Nitric Oxide-Responsive Proteins and Their Roles in Bacterial Biofilm Regulation.

Authors:  Sajjad Hossain; Lisa-Marie Nisbett; Elizabeth M Boon
Journal:  Acc Chem Res       Date:  2017-06-12       Impact factor: 22.384

5.  Regulation of membrane permeability by a two-component regulatory system in Pseudomonas aeruginosa.

Authors:  Yanping Wang; Unhwan Ha; Lin Zeng; Shouguang Jin
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

6.  Quorum sensing is not required for twitching motility in Pseudomonas aeruginosa.

Authors:  Scott A Beatson; Cynthia B Whitchurch; Annalese B T Semmler; John S Mattick
Journal:  J Bacteriol       Date:  2002-07       Impact factor: 3.490

7.  Human targets of Pseudomonas aeruginosa pyocyanin.

Authors:  Huimin Ran; Daniel J Hassett; Gee W Lau
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-06       Impact factor: 11.205

8.  Responses of well-differentiated airway epithelial cell cultures from healthy donors and patients with cystic fibrosis to Burkholderia cenocepacia infection.

Authors:  Umadevi Sajjan; Shaf Keshavjee; Janet Forstner
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

9.  Extragenic suppressor mutations that restore twitching motility to fimL mutants of Pseudomonas aeruginosa are associated with elevated intracellular cyclic AMP levels.

Authors:  Laura M Nolan; Scott A Beatson; Larry Croft; Peter M Jones; Anthony M George; John S Mattick; Lynne Turnbull; Cynthia B Whitchurch
Journal:  Microbiologyopen       Date:  2012-11-28       Impact factor: 3.139

10.  Extracellular ATP inhibits twitching motility-mediated biofilm expansion by Pseudomonas aeruginosa.

Authors:  Laura M Nolan; Rosalia Cavaliere; Lynne Turnbull; Cynthia B Whitchurch
Journal:  BMC Microbiol       Date:  2015-03-01       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.